// App-Quantinova.ai

SAT0603 : SYSTEMIC SCLEROSIS IS AN INDEPENDENT RISK FACTOR FOR ISCHEMIC HEART DISEASE WITH AN ADDITIONAL RISK IN THOSE POSITIVE FOR CERTAIN ANTI-PHOSPHOLIPID ANTIBODIES: A VERY LARGE CASE-CONTROL STUDY

Researchers

Presenter

  • A. Watad

Principal Investigators

  • D. Mcgonagle

  • N. L. Bragazzi

  • D. Comanesther

  • A. Cohen

  • M. Lidar

  • H. Amital

Medical Centers

  • Sheba Medical Center, Department of Medicine B’, Rheumatology Unit, Ramat Gan, Israel

  • NIHR - Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom

  • University of Genoa, Genoa, Italy

  • Clalit Health Services, Tel Aviv, Israel

  • Chaim Sheba Academic Medical Center, Pathology, Ramat Gan, Israel

Locations

  • Israel

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Coronary Artery Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Janssen Research & Development

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved